Clearside Biomedical

(OTC) CLSDQ

Current Price$0.30

Market Cap$1.57M

Since IPO (2016)-100%

5 Year-99%

1 Year-98%

1 Month+3%

Clearside Biomedical Financials at a Glance

Market Cap

$1.57M

Revenue (TTM)

$3.33M

Net Income (TTM)

$26.00M

EPS (TTM)

$-5.06

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$0.30

Volume

3,720

Open

$0.29

Price

$0.30

Volume

3,720

Open

$0.29

Previous Close

$0.30

Daily Range

$0.29 - $0.30

52-Week Range

$0.11 - $14.09

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$0.30

Volume

3,720

Open

$0.29

Previous Close

$0.30

Daily Range

$0.29 - $0.30

52-Week Range

$0.11 - $14.09

CLSDQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clearside Biomedical

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

George M. Lasezkay, PharmD

Website

www.clearsidebio.com

Headquarters

Alpharetta, GA 30005, US

CLSDQ Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

-7%

Net Income Margin

-8%

Return on Equity

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.57M

Shares Outstanding

5.23M

Volume

3.72K

Avg. Volume

23.96K

Financials (TTM)

Gross Profit

$1.51M

Operating Income

$28.88M

EBITDA

$24.35M

Operating Cash Flow

$24.70M

Capital Expenditure

$977.00K

Free Cash Flow

$25.68M

Cash & ST Invst.

$20.02M

Total Debt

$52.47M

Clearside Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$201.00K

-80.6%

Gross Profit

$201.00K

-80.6%

Gross Margin

100.00%

N/A

Market Cap

$1.57M

N/A

Market Cap/Employee

$49.07K

N/A

Employees

N/A

Net Income

$5.97M

+22.3%

EBITDA

$3.32M

+35.6%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$54.81M

-107.8%

Accounts Receivable

$266.00K

-66.2%

Inventory

$0.00

N/A

Long Term Debt

$61.23M

+23.4%

Short Term Debt

$384.00K

+2.9%

Return on Assets

-2.23%

N/A

Return on Invested Capital

-2.59%

N/A

Free Cash Flow

$5.48M

+8.1%

Operating Cash Flow

$5.48M

+7.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CYPHCypherpunk Technologies Inc.

CYPHCypherpunk Technologies Inc.$0.89+4.59%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.31+0.14%

VTVTvTv Therapeutics Inc.

VTVTvTv Therapeutics Inc.$32.24+3.10%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.47-2.37%

CGEMCullinan Therapeutics, Inc.

CGEMCullinan Therapeutics, Inc.$13.05+1.56%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.20+2.64%

CRVSCorvus Pharmaceuticals, Inc.

CRVSCorvus Pharmaceuticals, Inc.$15.19+5.34%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$199.57-0.05%

NOKNokia

NOKNokia$12.91+0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

FFord Motor Company

FFord Motor Company$12.08-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.47+0.05%

Questions About CLSDQ

What is the current price of Clearside Biomedical?

Clearside Biomedical is trading at $0.30 per share.

What is the 52-week range for Clearside Biomedical?

Over the past 52 weeks, Clearside Biomedical has traded between $0.11 and $14.09.

How much debt does Clearside Biomedical have?

As of the most recent reporting period, Clearside Biomedical reported total debt of $61.61M.

How much cash does Clearside Biomedical have on hand?

Clearside Biomedical reported $6.80M in cash and cash equivalents in its most recent financial results.

What is Clearside Biomedical’s dividend yield?

Clearside Biomedical does not currently have a dividend yield.

Clearside Biomedical

Clearside Biomedical Financials at a Glance

CLSDQ News

Why Clearside Biomedical Stock Surged Today

Clearside Biomedical Stock Down 26%: The "Positive" Data That Wasn't

Why Clearside Biomedical, Inc. Stock Gained 66.1% March

Why Clearside Biomedical Is Up for a Third Straight Day

Why Clearside Biomedical Jumped Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Clearside Biomedical

CLSDQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Clearside Biomedical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLSDQ

What is the current price of Clearside Biomedical?

What is the 52-week range for Clearside Biomedical?

How much debt does Clearside Biomedical have?

How much cash does Clearside Biomedical have on hand?

What is Clearside Biomedical’s dividend yield?

Premium Investing Services